Physician profile
Eric Hines
NPI 1689289282
$2,079.22
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $135 · 2021: $1,574 · 2022: $371.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $278.53 | 2020-2021 | |
| Lilly USA, LLC | $273.23 | 2020-2022 | |
| Novo Nordisk INC | $232.43 | 2021 | |
| Janssen Pharmaceuticals, INC | $196.42 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $166.46 | 2021-2022 | |
| Astrazeneca Pharmaceuticals Lp | $122.01 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $115.42 | 2021-2022 | |
| Glaxosmithkline, LLC. | $93.95 | 2021-2022 | |
| Collegium Pharmaceutical, INC. | $89.10 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $85.00 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $70.84 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $49.15 | 2021-2022 | |
| Genentech USA, INC. | $46.85 | 2022 | |
| Mylan Specialty L.P. | $38.80 | 2021 | |
| Allergan, INC. | $38.69 | 2020-2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $33.95 | 2022 | |
| Jazz Pharmaceuticals INC. | $29.07 | 2020-2022 | |
| Corium, LLC | $26.80 | 2021-2022 | |
| Organon LLC | $17.31 | 2022 | |
| Astellas Pharma US INC | $16.61 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $16.03 | 2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $14.96 | 2022 | |
| Amgen INC. | $13.88 | 2021 | |
| Adlon Therapeutics L.P. | $13.73 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Hines listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.